| Literature DB >> 15377478 |
Monica Galli, Francesca Elice, Claudia Crippa, Benedetto Comotti, Francesco Rodeghiero, Tiziano Barbui.
Abstract
Among 199 patients treated with thalidomide for multiple myeloma, four thromboses occurred in 49 cases during erythropoietin therapy (prevalence 8.1%; annual rate 7.25%), and another 14 events occurred in patients not on erythropoietin (9.3%; 7.56%). Thus, erythropoietin would seem not to increase the risk of thrombosis of myeloma patients receiving thalidomide.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15377478
Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941